| __timestamp | Amneal Pharmaceuticals, Inc. | United Therapeutics Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 449634000 | 1162636000 |
| Thursday, January 1, 2015 | 499226000 | 1396725000 |
| Friday, January 1, 2016 | 597455000 | 1526100000 |
| Sunday, January 1, 2017 | 526178000 | 1619600000 |
| Monday, January 1, 2018 | 716403000 | 1429100000 |
| Tuesday, January 1, 2019 | 352997000 | 1331200000 |
| Wednesday, January 1, 2020 | 628393000 | 1375200000 |
| Friday, January 1, 2021 | 768973000 | 1563000000 |
| Saturday, January 1, 2022 | 784708000 | 1789600000 |
| Sunday, January 1, 2023 | 820565000 | 2070000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, financial performance is a key indicator of a company's resilience and innovation. Over the past decade, United Therapeutics Corporation has consistently outperformed Amneal Pharmaceuticals, Inc. in terms of gross profit. From 2014 to 2023, United Therapeutics saw a remarkable 78% increase in gross profit, peaking at $2.07 billion in 2023. In contrast, Amneal Pharmaceuticals experienced a 82% growth, reaching $820 million in the same year.
This trend highlights United Therapeutics' robust market strategy and product portfolio, which have enabled it to maintain a significant lead. Meanwhile, Amneal's steady growth reflects its efforts to expand its market presence. As the pharmaceutical landscape continues to shift, these companies' financial trajectories offer valuable insights into their strategic directions and market adaptability.
Gross Profit Analysis: Comparing Merck & Co., Inc. and Amneal Pharmaceuticals, Inc.
Gross Profit Analysis: Comparing AstraZeneca PLC and Amneal Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs United Therapeutics Corporation: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Takeda Pharmaceutical Company Limited vs United Therapeutics Corporation
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or United Therapeutics Corporation
Biogen Inc. and United Therapeutics Corporation: A Detailed Gross Profit Analysis
Analyzing R&D Budgets: United Therapeutics Corporation vs Amneal Pharmaceuticals, Inc.
United Therapeutics Corporation vs Taro Pharmaceutical Industries Ltd.: A Gross Profit Performance Breakdown
Genmab A/S vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Viatris Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Ascendis Pharma A/S and Amneal Pharmaceuticals, Inc. Trends
Key Insights on Gross Profit: Amneal Pharmaceuticals, Inc. vs HUTCHMED (China) Limited